Stemcell Technologies expands relationship with BioLife

08/14/2013 | Pharmaceutical Business Review Online

British Columbia-based Stemcell Technologies has expanded its relationship with BioLife Solutions and will use BioLife's CryoStor media with 50 new primary cell products involving peripheral blood, bone marrow, umbilical cord tissue and umbilical cord blood. The cell product portfolio is intended for use in research.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC